Clinical Trials Browser

Phase 2 × NETWORK × valrubicin × Clear all

NCT00003129 2023-06-22

Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms